We use cookies to deliver our online services. Details of the cookies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you agree to our use of cookies. To close this message click close.

Global Regulators Face Up to "Biosimilar" Complexity

15 April 2005

This article gives an up-to-date summary of the current EU situation on "follow-on biologics" and describes the draft guideline and concept papers issued by the EMEA in November/ December 2004. This article follows on from the Hogan & Hartson EU Bulletin published in the summer of 2004.
Loading data